skinny.

Latest / Squawk Pod

Eli Lilly CEO on Antibody Trial’s Finish; CEOs Get Out the Vote

The National Institutes of Health has halted one of Eli Lilly’s coronavirus antibody trials, having found that the combination of Lilly’s antibody drug and Gilead’s remdesivir does not result in a marked improvement in hospitalized Covid-19 patients. Eli Lilly CEO David Ricks discusses what’s next for the antibody that’s proven successful in treating milder Covid cases, and he addresses the company’s third quarter financials. CNBC’s All America Survey reveals that while Joe Biden is leading President Trump in the election polls, both candidates must now rely on niche populations for victory…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.